Literature DB >> 26211666

CD4+VEGFR1(HIGH) T cell as a novel Treg subset regulates inflammatory bowel disease in lymphopenic mice.

Jin-Young Shin1,2,3,4, Il-Hee Yoon1,2,3,4, Jong-Hyung Lim1,2,3,4, Jun-Seop Shin1,2,3,4, Hye-Young Nam1,2,3,4, Yong-Hee Kim1,2,3,4, Hyoung-Soo Cho1,2,3,4, So-Hee Hong1,2,3,4, Jung-Sik Kim1,2,3,4, Won-Woo Lee1,4, Chung-Gyu Park1,2,3,4.   

Abstract

Regulatory T cells (Tregs) are a specialized subpopulation of T cells that control the immune response and thereby maintain immune system homeostasis and tolerance to self-antigens. Many subsets of CD4(+) Tregs have been identified, including Foxp3(+), Tr1, Th3, and Foxp3neg iT(R)35 cells. In this study, we identified a new subset of CD4(+)VEGFR1(high) Tregs that have immunosuppressive capacity. CD4(+)VEGFR1high T cells, which constitute approximately 1.0% of CD4(+) T cells, are hyporesponsive to T-cell antigen receptor stimulation. Surface marker and FoxP3 expression analysis revealed that CD4(+)VEGFR1(high) T cells are distinct from known Tregs. CD4(+)VEGFR1(high) T cells suppressed the proliferation of CD4(+)CD25(-) T cell as efficiently as CD4(+)CD25(high) natural Tregs in a contact-independent manner. Furthermore, adoptive transfer of CD4(+)VEGFR1(+) T cells from wild type to RAG-2-deficient C57BL/6 mice inhibited effector T-cell-mediated inflammatory bowel disease. Thus, we report CD4(+) VEGFR1(high) T cells as a novel subset of Tregs that regulate the inflammatory response in the intestinal tract.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26211666      PMCID: PMC4579660          DOI: 10.1038/cmi.2015.71

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  66 in total

1.  Cell interactions in the induction of tolerance: the role of thymic lymphocytes.

Authors:  R K Gershon; K Kondo
Journal:  Immunology       Date:  1970-05       Impact factor: 7.397

2.  Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells.

Authors:  H L Weiner
Journal:  Immunol Rev       Date:  2001-08       Impact factor: 12.988

3.  Infectious immunological tolerance.

Authors:  R K Gershon; K Kondo
Journal:  Immunology       Date:  1971-12       Impact factor: 7.397

4.  5,6-carboxyfluorescein diacetate succinimidyl ester-labeled apoptotic and necrotic as well as detergent-treated cells can be traced in composite cell samples.

Authors:  I E Dumitriu; W Mohr; W Kolowos; P Kern; J R Kalden; M Herrmann
Journal:  Anal Biochem       Date:  2001-12-15       Impact factor: 3.365

5.  VEGF inhibits T-cell development and may contribute to tumor-induced immune suppression.

Authors:  Joyce E Ohm; Dmitry I Gabrilovich; Gregory D Sempowski; Ekaterina Kisseleva; Kelly S Parman; Sorena Nadaf; David P Carbone
Journal:  Blood       Date:  2003-02-13       Impact factor: 22.113

6.  Distinct roles for the OX40-OX40 ligand interaction in regulatory and nonregulatory T cells.

Authors:  Ikuo Takeda; Shoji Ine; Nigel Killeen; Lishomwa C Ndhlovu; Kazuko Murata; Susumu Satomi; Kazuo Sugamura; Naoto Ishii
Journal:  J Immunol       Date:  2004-03-15       Impact factor: 5.422

Review 7.  The biology of VEGF and its receptors.

Authors:  Napoleone Ferrara; Hans-Peter Gerber; Jennifer LeCouter
Journal:  Nat Med       Date:  2003-06       Impact factor: 53.440

8.  Vascular endothelial growth factor/vascular permeability factor is detectable in the sera of tumor-bearing mice and cancer patients.

Authors:  S Kondo; M Asano; K Matsuo; I Ohmori; H Suzuki
Journal:  Biochim Biophys Acta       Date:  1994-03-31

9.  Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice.

Authors:  F Powrie; M W Leach; S Mauze; L B Caddle; R L Coffman
Journal:  Int Immunol       Date:  1993-11       Impact factor: 4.823

10.  CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice. Disease development is prevented by cotransfer of purified CD4+ T cells.

Authors:  P J Morrissey; K Charrier; S Braddy; D Liggitt; J D Watson
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

View more
  2 in total

1.  T regulatory cell mediated immunotherapy for solid organ transplantation: A clinical perspective.

Authors:  Mohammad Afzal Khan
Journal:  Mol Med       Date:  2016-11-22       Impact factor: 6.354

2.  Identification of Candidate Genes Related to Inflammatory Bowel Disease Using Minimum Redundancy Maximum Relevance, Incremental Feature Selection, and the Shortest-Path Approach.

Authors:  Fei Yuan; Yu-Hang Zhang; Xiang-Yin Kong; Yu-Dong Cai
Journal:  Biomed Res Int       Date:  2017-02-14       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.